Videos

Get ready for the 2021 AUA annual meeting with this preview of non-malignant topics.

“We have to be really careful prescribing tramadol and be aware that [it] can have really variable effects for patients,” says Sarah F. Faris, MD.

“Through these 2 small punctures, we can manipulate the device with the methodology to sample the entire prostate, both anterior apical and the posterior regions, where we find the vast majority of our cancers,” says Matthew A. Allaway, MD.

“Appropriately selecting your patient will result in a successful telehealth visit,” says Nitya E. Abraham, MD.

“The transperineal [prostate biopsy] approach is safer because the needles are passed through the perineal skin…so, we can sterilize that skin and if we enter through that passageway, we mitigate, if not eliminate, the risk of infection and sepsis,” says Matthew J. Allaway, MD.

“Transgender and gender-diverse people are at a higher risk of a multitude of mental health diagnoses, [which] really lends itself to a sensitive psycho-social history regardless of the specialty,” says David A. Klein, MD, MPH.

“The 3 major barriers we face [are] training, equipment, and reimbursement,” says Matthew A. Allaway, MD.

“The notable feature was that the bleeding risk is very small. In our particular group, it was less than 1%,” says Jai Seth, MD.

“This is an important form of providing health care, especially for people who have a lot of limitations in coming for in-person visits,” says Nitya E. Abraham, MD.

“From a clinician’s perspective…these medications and these diagnoses happen when there’s not enough care from the start,” says David A. Klein, MD, MPH.

“We found a majority of patients with televisits were satisfied, with many saying it was easy to schedule, easy to comfortably share sensitive information with their doctor, and with the most surprising [finding] being 80% saying they would choose it again over an in-person visit,” says Christina Shin, BA.

Kyle Wood, MD, comments on the presenting signs and symptoms of enteric hyperoxaluria and complications of untreated disease.

“In terms of patients having Botox, we have to be individualized to some extent where if you feel someone's at very high risk of bleeding…then maybe you will stop the blood thinners,” says Jai Seth, MD.

Risk factors Dr.Zhang highlights include site of metastases, PSA response, and metastases burden.

“Botox to [the] bladder has, in some ways, changed the paradigm of treatment for [overactive bladder],” says Jai Seth, MD.

“The MRI/ultrasound-guided transperineal approach allows easy access to anterior prostate tumors,” says Marc A. Bjurlin, DO, MSc, FACOS, in this video.

Amy E. Krambeck, MD, discusses her recent trial comparing the efficacy of Trilogy and ShockPulse-SE lithotripters used in percutaneous nephrolithotomy.

Susan F. Slovin, MD, PhD, highlights 177Lu-PSMA-617 and the radiopharmaceutical revolution in metastatic castration-resistant prostate cancer.

“[Patients] want to ensure that all of their episodes of UTIs are seen as a chronic condition that’s really debilitating in their life, and not just single episodes for which they need antibiotics,” says Victoria C. Scott, MD.

“Giving them options where they don’t need to necessarily jump to antibiotic therapy…are key aspects of management for a lot of these patients,” says Victoria C. Scott, MD.

"A lot of ancillary providers want more privileges that the physician has, and we have to be the guardians and the reason we're doing this is to protect our patients so that they get the best care available to them," says William C. Reha, MD, MBA.

“The frustration component that we found and heard amongst these women was with their providers really focusing their care around antibiotics…[and] not spending enough time on education with prevention strategies,” says Victoria C. Scott, MD.

“Being able to have a follow-up visit that is convenient, that saves time, that saves money, but that can allow you to put everything together for the patient…is still a very valuable tool,” says Juan José Andino, MD.

“The feedback has been very positive from both physicians and patients,” author Madeline Zech Ruiz says of her book “I Married a Urologist.”

“With more people using [telehealth], with more people essentially forced by the pandemic to have to offer care at least at some point virtually, there is comfort and…more interest in ensuring that it remains an option,” says Juan José Andino, MD.

“Everybody in our department participates in some quantity of telehealth within their regular scheduled practice,” says Kara L. Watts, MD, in this video.

Daniel C. Danila, MD, discusses choosing among the androgen receptor inhibitors darolutamide, enzalutamide, and apalutamide when treating patients with castration-resistant prostate cancer.

“[Telemedicine is] not just a form of health care delivery for emergency pandemic situations, this is something that is here to stay,” says Kara L. Watts, MD, in this video.

"None of our patients had unexpected appointments that had to be made after their video encounters…supporting this idea that at least in urology, it seems that telehealth is a substitute for inpatient care when appropriately selected by the physician,” says Juan José Andino, MD.

Jingsong Zhang, MD, PhD, discusses how the site of metastases impacts his approach to treatment selection for patients with metastatic castration-resistant prostate cancer.